AstraZeneca (AZN) RNS Announcements

Add to Alert list
Date Time Source Announcement
13 Jun 2002 04:00 PM
RNS
Holding(s) in Company
13 Jun 2002 07:00 AM
RNS
Purchase of Own Securities
10 Jun 2002 07:00 AM
RNS
Purchase of Own Securities
07 Jun 2002 07:00 AM
RNS
Purchase of Own Securities
05 Jun 2002 09:38 AM
RNS
Regulatory Approval
05 Jun 2002 07:00 AM
RNS
Purchase of Own Securities
30 May 2002 07:00 AM
RNS
Purchase of Own Securities
29 May 2002 07:00 AM
RNS
Purchase of Own Securities
28 May 2002 07:00 AM
RNS
Purchase of Own Securities
24 May 2002 01:00 PM
RNS
Retirement
24 May 2002 07:00 AM
RNS
Purchase of Own Securities
23 May 2002 07:00 AM
RNS
Purchase of Own Securities
21 May 2002 07:00 AM
RNS
Purchase of Own Securities
20 May 2002 09:00 AM
RNS
Iressa Study Results
17 May 2002 07:00 AM
RNS
Purchase of Own Securities
16 May 2002 08:00 AM
RNS
Crestor Co-Marketing
15 May 2002 07:00 AM
RNS
Purchase of Own Securities
14 May 2002 07:00 AM
RNS
Purchase of Own Securities
13 May 2002 07:00 AM
RNS
Purchase of Own Securities
10 May 2002 07:00 AM
RNS
Purchase of Own Securities
09 May 2002 07:00 AM
RNS
Purchase of Own Securities
08 May 2002 05:10 PM
RNS
Director Shareholding
07 May 2002 04:00 PM
RNS
Holding(s) in Company
07 May 2002 07:00 AM
RNS
Purchase of Own Securities
03 May 2002 07:00 AM
RNS
Purchase of Own Securities
02 May 2002 07:00 AM
RNS
Purchase of Own Securities
01 May 2002 07:00 AM
RNS
Purchase of Own Securities
29 Apr 2002 07:00 AM
RNS
Purchase of Own Securities
26 Apr 2002 04:00 PM
RNS
Director Shareholding
26 Apr 2002 07:23 AM
RNS
FDA Approval - Faslodex
26 Apr 2002 07:20 AM
RNS
Purchase of Own Securities
25 Apr 2002 03:54 PM
RNS
Result of AGM
25 Apr 2002 10:00 AM
RNS
1st Quarter Results - Part 2
25 Apr 2002 10:00 AM
RNS
1st Quarter Results - Part 1
24 Apr 2002 03:10 PM
RNS
AstraZeneca Wins Case
02 Apr 2002 03:30 PM
RNS
Director Shareholding
02 Apr 2002 03:30 PM
RNS
Director Shareholding
25 Mar 2002 07:00 AM
RNS
Purchase of Own Securities
22 Mar 2002 05:17 PM
RNS
Circular to Shareholders
22 Mar 2002 07:00 AM
RNS
Purchase of Own Securities
20 Mar 2002 07:00 AM
RNS
Purchase of Own Securities
19 Mar 2002 07:00 AM
RNS
Purchase of Own Securities
18 Mar 2002 11:00 AM
RNS
Board Appointments
18 Mar 2002 07:00 AM
RNS
Purchase of Own Securities
15 Mar 2002 07:00 AM
RNS
Purchase of Own Securities
13 Mar 2002 07:00 AM
RNS
Purchase of Own Securities
12 Mar 2002 07:00 AM
RNS
Purchase of Own Securities
07 Mar 2002 07:00 AM
RNS
Purchase of Own Securities
06 Mar 2002 10:01 AM
RNS
Omeprazole Patent Decision
06 Mar 2002 07:00 AM
RNS
Purchase of Own Securities

AstraZeneca plc is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England.

It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation. It was involved in developing the Oxford–AstraZeneca COVID-19 vaccine.

Astra Zeneca share price launched at 605p in 1993.

UK 100

Latest directors dealings